Pharmaron Beijing Co., Ltd. (SHE:300759)
China · Delayed Price · Currency is CNY 30.72
+1.76 (6.08%)
Aug 13, 2025, 2:45 PM CST
United States Steel Market Cap
Pharmaron Beijing has a market cap or net worth of 51.52 billion as of August 13, 2025. Its market cap has increased by 60.14% in one year.
Market Cap
51.52B
Enterprise Value
55.39B
Revenue
12.70B
Ranking
n/a
PE Ratio
29.22
Stock Price
$30.72
Market Cap Chart
Since January 28, 2019, Pharmaron Beijing's market cap has increased from 7.24B to 51.52B, an increase of 611.65%. That is a compound annual growth rate of 34.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 51.52B | 23.11% |
| Dec 31, 2024 | 41.85B | -11.66% |
| Dec 29, 2023 | 47.37B | -38.44% |
| Dec 30, 2022 | 76.95B | -27.67% |
| Dec 31, 2021 | 106.40B | 12.84% |
| Dec 31, 2020 | 94.29B | 140.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 405.72B |
| Shenzhen Mindray Bio-Medical Electronics | 283.36B |
| WuXi AppTec | 267.28B |
| Zhangzhou Pientzehuang Pharmaceutical., | 121.39B |
| Aier Eye Hospital Group | 121.03B |
| Sichuan Biokin Pharmaceutical | 118.80B |
| Shanghai United Imaging Healthcare | 107.46B |
| Yunnan Baiyao Group Co.,Ltd | 99.83B |